The Unveiling of Securities Fraud Lawsuit Against Outset Medical, Inc.
LOS ANGELES, Oct. 4, 2024 — The possibility for investors to spearhead a securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) presents itself.
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
If you are a shareholder who suffered a loss, click here to participate.
The complaint suggests that, throughout the Class Period, Defendants failed to disclose vital information to investors regarding the marketing and FDA approvals of Tablo products. This lack of transparency led to misleading statements about the Company’s business, operations, and prospects.
For updates on Twitter, follow us at twitter.com/FRC_LAW.
If you wish to learn more about this class action, or if you have questions regarding this lawsuit, please contact Frank R. Cruz at 2121 Avenue of the Stars, Suite 800, Century City, California 90067, or visit our website at www.frankcruzlaw.com.
Kindly note that this press release may be considered Attorney Advertising in some jurisdictions under applicable law and ethical rules.
View original content to download multimedia: https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-302267951.html
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
Market News and Data brought to you by Benzinga APIs